A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier - Sturm, S; Günther, A; Jaber, B (Br J Clin Pharmacol, 2019)
, et al.